A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.

Our study suggests that when methadone and buprenorphine are equally appropriate options for the treatment of OUD in pregnant women, buprenorphine may add the additional benefit of reduced risk of newborn NAS.